These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 1001857)

  • 1. [Antibiotic therapy in the high risk patient (hematologic study)].
    Tura S; Ruggero D
    G Clin Med; 1976; 57(3-4):92-104. PubMed ID: 1001857
    [No Abstract]   [Full Text] [Related]  

  • 2. [Infectious complications in malignant hematopoietic diseases under an incompletely protective regimen].
    Mociková K; Faber E; Svác J; Zaloudek F
    Vnitr Lek; 1987 Jul; 33(7):571-8. PubMed ID: 3660701
    [No Abstract]   [Full Text] [Related]  

  • 3. The use of synergistic combinations of antibiotics in patients with haematological diseases.
    Klastersky J
    Clin Haematol; 1976 Jun; 5(2):361-77. PubMed ID: 780029
    [No Abstract]   [Full Text] [Related]  

  • 4. Management of bacterial infections in haematological patients.
    Galea G
    Br J Hosp Med; 1982 Jul; 28(1):74, 76, 79 passim. PubMed ID: 6289951
    [No Abstract]   [Full Text] [Related]  

  • 5. Impact of fluoroquinolone prophylaxis on reduced infection-related mortality among patients with neutropenia and hematologic malignancies.
    Reuter S; Kern WV; Sigge A; Döhner H; Marre R; Kern P; von Baum H
    Clin Infect Dis; 2005 Apr; 40(8):1087-93. PubMed ID: 15791505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of bacterial infection in neutropenic patients with hematologic malignancies. A randomized, multicenter trial comparing norfloxacin with ciprofloxacin. The GIMEMA Infection Program. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto.
    Ann Intern Med; 1991 Jul; 115(1):7-12. PubMed ID: 2048868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of cefmetazole and piperacillin with or without tobramycin for infections in patients with hematological disorders.
    Nagao T; Komatsuda M; Yamauchi K; Nozaki H; Arimori S
    Tokai J Exp Clin Med; 1981 Oct; 6(4):415-20. PubMed ID: 6459664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antibiotic therapy during the aplastic phases of acute leukemia].
    Bauters F
    Lille Med; 1975 Dec; 20(10):916-20. PubMed ID: 1207360
    [No Abstract]   [Full Text] [Related]  

  • 9. High-risk febrile neutropenia in Auckland 2003-2004: the influence of the microbiology laboratory on patient treatment and the use of pathogen-specific therapy.
    Ritchie S; Palmer S; Ellis-Pegler R
    Intern Med J; 2007 Jan; 37(1):26-31. PubMed ID: 17199841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Where do we go from here?
    Pizzo PA
    J Antimicrob Chemother; 2009 May; 63 Suppl 1():i16-7. PubMed ID: 19372174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy of infections in cancer patients: a review.
    Sim SK
    Am J Hosp Pharm; 1975 Jan; 32(1):35-44. PubMed ID: 1092159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacterial infections in the compromised host with special emphasis on patients with hematologic malignancies.
    Madhavan T
    Compr Ther; 1984 Jan; 10(1):19-24. PubMed ID: 6692667
    [No Abstract]   [Full Text] [Related]  

  • 13. [Oral manifestations of hemopathies. 2. Stomatological aspects of diseases involving leukocytes].
    Tsamis I; Szpirglas H; Mangiante P; Casabona E
    Minerva Stomatol; 1981; 30(4):281-8. PubMed ID: 7024777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Infections in agranulocytosis and their treatment].
    Dao Ch
    Sem Hop; 1975 Feb; 51(10):677-84. PubMed ID: 175456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Germ and hematology: underlying disease influences diversity of germ spectra and antibiotic therapy.
    Schalk E; Tammer I; Heidel FH
    Infect Control Hosp Epidemiol; 2014 Feb; 35(2):208-10. PubMed ID: 24442091
    [No Abstract]   [Full Text] [Related]  

  • 16. [Antimicrobial prophylaxis and therapy in neutropenia].
    Link H
    Mycoses; 2003; 46 Suppl 2():21-32. PubMed ID: 15055140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The evolution of antibiotic therapy for neutropenic patients.
    Bodey GP
    Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2660-5. PubMed ID: 10068270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Why empirical therapy?
    Klastersky J
    J Antimicrob Chemother; 2009 May; 63 Suppl 1():i14-5. PubMed ID: 19372173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical study on fluoroquinolone prophylaxis in neutropenia patients with acute leukemia].
    Qin TJ; Mi YC; Feng SZ; Li DP; Wei JL; Yang DL; Han MZ; Wang JX; Bian SG
    Zhonghua Yi Xue Za Zhi; 2007 May; 87(20):1389-93. PubMed ID: 17785058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical evaluation of ceftizoxime intravenous administration in severe infections associated with hematologic disorders. Niigata Infection Study Group].
    Moriyama Y; Shibata A; Ito M; Iizumi T; Watabe T; Sato M; Kurokawa I; Sugiyama K; Sanada M; Nakamura T
    Jpn J Antibiot; 1986 Mar; 39(3):807-14. PubMed ID: 3461176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.